Ronald A. Morton

5.2k total citations · 1 hit paper
49 papers, 4.0k citations indexed

About

Ronald A. Morton is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Ronald A. Morton has authored 49 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Ronald A. Morton's work include Prostate Cancer Treatment and Research (21 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Cancer-related gene regulation (10 papers). Ronald A. Morton is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Cancer-related gene regulation (10 papers). Ronald A. Morton collaborates with scholars based in United States, South Korea and Japan. Ronald A. Morton's co-authors include Mitchell S. Steiner, William B. Isaacs, Patrick C. Walsh, Patrick C. Walsh, G. Steven Bova, James D. Brooks, Charles M. Ewing, David M. Quinlan, P A Campbell and Wu‐Shiun Hsieh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Ronald A. Morton

49 papers receiving 3.8k citations

Hit Papers

Cytidine methylation of regulatory sequences near the pi-... 1994 2026 2004 2015 1994 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
    1994 641 citations Ronald A. Morton, James D. Brooks et al. profile →

Peers

Ronald A. Morton
Mikio Igawa Japan
Mitchell S. Steiner United States
Seiichiro Ozono Japan
Norihiko Tsuchiya Japan
Jasmin Bektić Austria
Kazuto Ito Japan
Naoki Terada Japan
Fritz H. Schroeder Netherlands
Michael L. Cher United States
Hidefumi Kinoshita Japan
Mikio Igawa Japan
Ronald A. Morton
Citations per year, relative to Ronald A. Morton Ronald A. Morton (= 1×) peers Mikio Igawa

Countries citing papers authored by Ronald A. Morton

Since Specialization
Citations

This map shows the geographic impact of Ronald A. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald A. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald A. Morton more than expected).

Fields of papers citing papers by Ronald A. Morton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald A. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald A. Morton. The network helps show where Ronald A. Morton may publish in the future.

Co-authorship network of co-authors of Ronald A. Morton

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald A. Morton. A scholar is included among the top collaborators of Ronald A. Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald A. Morton. Ronald A. Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Coss, Christopher C., Amanda Jones, Deanna N. Parke, et al.. (2012). Preclinical Characterization of a Novel Diphenyl Benzamide Selective ERα Agonist for Hormone Therapy in Prostate Cancer. Endocrinology. 153(3). 1070–1081. 6 indexed citations
4.
Saylor, Philip J., Ronald A. Morton, Michael L. Hancock, et al.. (2011). Factors Associated With Vertebral Fractures in Men Treated With Androgen Deprivation Therapy for Prostate Cancer. The Journal of Urology. 186(2). 482–486. 22 indexed citations
5.
Koh, Moon Soo, et al.. (2005). Prostate specific antigen as a clinical biomarker for prostate cancer: What’s the take home message?. Cancer Biology & Therapy. 4(4). 377–381. 9 indexed citations
6.
Kim, Isaac Yi, et al.. (2004). Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells. Oncogene. 23(46). 7651–7659. 65 indexed citations
7.
Kim, Isaac Yi, Do Hwan Seong, Byung-Chul Kim, et al.. (2002). Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.. PubMed. 62(13). 3649–53. 59 indexed citations
8.
Morton, Ronald A., et al.. (2001). INDICATIONS FOR PELVIC LYMPHADENECTOMY IN PROSTATE CANCER. Urologic Clinics of North America. 28(3). 491–498. 45 indexed citations
9.
Kim, Isaac Yi, Dong Hyeon Lee, Han Jong Ahn, et al.. (2000). Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues.. PubMed. 60(11). 2840–4. 83 indexed citations
10.
Kattan, Michael W., et al.. (1999). Race is not an independent predictor of positive surgical margins after radical prostatectomy. Urology. 54(5). 869–874. 16 indexed citations
11.
Isaacs, William B., G. Steven Bova, Ronald A. Morton, et al.. (1998). Molecular Biology of Prostate Cancer. PubMed. 21(5). 514–21. 56 indexed citations
12.
Morton, Ronald A., et al.. (1996). Hypermethylation of Chromosome 17P Locust D17S5 in Human Prostate Tissue. The Journal of Urology. 156(2). 512–516. 32 indexed citations
13.
Morton, Ronald A., Charles M. Ewing, John J. Watkins, & William B. Isaacs. (1995). The E-cadherin cell-cell adhesion pathway in urologic malignancies. World Journal of Urology. 13(6). 364–368. 15 indexed citations
14.
Isaacs, William B., G. Steven Bova, Ronald A. Morton, et al.. (1995). Molecular biology of prostate cancer progression.. PubMed. 23. 19–32. 42 indexed citations
15.
Morton, Ronald A.. (1994). Racial differences in adenocarcinoma of the prostate in North American men. Urology. 44(5). 637–645. 115 indexed citations
16.
Isaacs, William B., G. Steven Bova, Ronald A. Morton, et al.. (1994). Genetic Alterations in Prostate Cancer. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 653–659. 44 indexed citations
17.
McPherson, John D., Ronald A. Morton, Charles M. Ewing, et al.. (1994). Assignment of the Human α-Catenin Gene (CTNNA1) to Chromosome 5q21-q22. Genomics. 19(1). 188–190. 30 indexed citations
18.
Morton, Ronald A., Charles M. Ewing, Akira Nagafuchi, Sachiko Tsukita, & William B. Isaacs. (1993). Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.. PubMed. 53(15). 3585–90. 250 indexed citations
19.
Tempany, Clare M., Ronald A. Morton, & Fray F. Marshall. (1992). MRI of the Renal Veins. Journal of Computer Assisted Tomography. 16(6). 929–934. 13 indexed citations
20.
Morton, Ronald A., John T. Isaacs, & William B. Isaacs. (1990). Differential effects of growth factor antagonists on neoplastic and normal prostatic cells. The Prostate. 17(4). 327–336. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikio Igawa Breakdown of academic impact, for papers by Mitchell S. Steiner Breakdown of academic impact, for papers by Seiichiro Ozono Breakdown of academic impact, for papers by Norihiko Tsuchiya Breakdown of academic impact, for papers by Jasmin Bektić Breakdown of academic impact, for papers by Kazuto Ito Breakdown of academic impact, for papers by Naoki Terada Breakdown of academic impact, for papers by Fritz H. Schroeder Breakdown of academic impact, for papers by Michael L. Cher Breakdown of academic impact, for papers by Hidefumi Kinoshita
Rankless by CCL
2026